Since the increase in IRS2 levels has been related with an attenuation in Tau hyperphosphorylation [47], we evaluated the glycogen synthase kinase-3β (GSK3β), a main Tau kinase converging between AD and insulin resistance. The gene discussed is MAPT; the disease is Alzheimer disease.